CorMedix Inc. Company Profile
NASDAQ: CRMDHealth CareBiotechnology: Pharmaceutical PreparationsUSD
At close: Oct 8, 4:00 PM ET · Delayed 15 min
CorMedix at a glance
CorMedix Inc. (NASDAQ: CRMD) is a Biotechnology: Pharmaceutical Preparations company in the Health Care sector headquartered in Parsippany, NJ. CorMedix is led by Mr. Joseph Todisco MBA and employs about 191 people. At a market capitalization of $567.4 million, it is considered a small-cap company.
Its SEC Central Index Key (CIK) is 0001410098, which identifies the company's filings on EDGAR.
Summary generated from market data by MetaCap's automated system. Methodology
What does CorMedix do?
CorMedix Inc., a biopharmaceutical company, focuses on developing and commercializing therapeutic products for life-threatening diseases and conditions in the United States. Its lead product candidate is DefenCath, an antimicrobial catheter lock solution to reduce the incidence of catheter-related bloodstream infections in adult patients with kidney failure. CorMedix Inc. was formerly known as Picton Holding Company, Inc. and changed its name to CorMedix, Inc. in January 2007. The company was incorporated in 2006 and is based in Parsippany, New Jersey.
Business description based on the company's public filings.
Company information
- Legal name
- CorMedix Inc.
- Ticker
- NASDAQ: CRMD
- Sector
- Health Care
- Industry
- Biotechnology: Pharmaceutical Preparations
- CEO
- Mr. Joseph Todisco MBA
- Employees
- 191
- Headquarters
- 389 Interpace Pkwy, Parsippany, NJ, United States
- Phone
- 908 517 9500
- Website
- cormedix.com
- Market cap
- $567.43M
- SEC CIK
- 0001410098
Companies similar to CorMedix
| Company | Price | % Chg | Market cap | Compare |
|---|---|---|---|---|
| STTKShattuck Labs Inc. | 5.66 | +0.09% | $568.06M | vs CRMD |
| MNPRMonopar Therapeutics Inc. | 83.98 | +0.24% | $563.69M | vs CRMD |
| EVOEvotec SE ADR | 1.57 | -2.48% | $557.96M | vs CRMD |
| ACRSAclaris Therapeutics Inc. | 3.79 | +11.47% | $557.88M | vs CRMD |
| CTMXCytomX Therapeutics Inc. | 2.47 | -3.14% | $538.21M | vs CRMD |
| BLSMBlossomHill Therapeutics Inc. | 16.88 | +1.63% | $536.53M | vs CRMD |
| OCSOculis Holding AG | 8.66 | +1.88% | $533.35M | vs CRMD |
| CBIOCrescent Biopharma Inc. | 14.12 | +4.67% | $524.51M | vs CRMD |